Heartflow
Heartflow — Decisive Coronary Care
Heartflow’s mission is to transform coronary artery disease (CAD) from the leading cause of death into a disease that can be managed for life. We combine advanced AI and medical imaging to give clinicians a detailed, patient-specific 3D model of the heart so they can personalize diagnosis and treatment decisions.
What we do
Our core product, Heartflow One, turns Coronary CTA (CCTA) scans into physiological and anatomical analyses including FFRCT (blood flow assessment), Roadmap Analysis, and Plaque Analysis. The platform supports clinical, operational, technical and financial workflows to help clinicians identify, decide and manage CAD.
Impact and evidence
- >650,000 patients treated using Heartflow technology
- >1,800 institutions using Heartflow
- Extensive peer‑reviewed publications and clinical evidence supporting use
